APA (7th ed.) Citation

Issa, M., Klamer, B. G., Mladkova, N., Laliotis, G. I., Karivedu, V., Bhateja, P., . . . Bonomi, M. (2022). Update of a prognostic survival model in head and neck squamous cell carcinoma patients treated with immune checkpoint inhibitors using an expansion cohort. BMC Cancer, 22(1), 1. https://doi.org/10.1186/s12885-022-09809-5

Chicago Style (17th ed.) Citation

Issa, Majd, et al. "Update of a Prognostic Survival Model in Head and Neck Squamous Cell Carcinoma Patients Treated with Immune Checkpoint Inhibitors Using an Expansion Cohort." BMC Cancer 22, no. 1 (2022): 1. https://doi.org/10.1186/s12885-022-09809-5.

MLA (9th ed.) Citation

Issa, Majd, et al. "Update of a Prognostic Survival Model in Head and Neck Squamous Cell Carcinoma Patients Treated with Immune Checkpoint Inhibitors Using an Expansion Cohort." BMC Cancer, vol. 22, no. 1, 2022, p. 1, https://doi.org/10.1186/s12885-022-09809-5.